+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic Factors for Survival After Extracorporeal Membrane Oxygenation for Cardiogenic Shock

Prognostic Factors for Survival After Extracorporeal Membrane Oxygenation for Cardiogenic Shock

Asaio Journal 2019:

The aim of this study is to examine factors that can predict mortality in patients that have veno-arterial extracorporeal membrane oxygenation (VA-ECMO) instituted for cardiogenic shock. A single-center, retrospective study of 127 patients who underwent VA-ECMO for cardiogenic shock between January 2003 and December 2017 was conducted. Eighty-three (65%) patients survived to weaning or bridging therapy. Complications on VA-ECMO include: hemorrhage (40%), stroke (14%), requirement for dialysis (42%), and limb ischemia (24%). Univariate analysis revealed shorter ECMO duration, higher body mass index, preimplantation creatinine > 100 mmol/l, lower preimplantation serum albumin, and the development of stroke or limb ischemia on ECMO to be significantly associated with mortality while on ECMO. Multivariate analysis by logistic regression found shorter ECMO duration and lower preimplantation serum albumin to be significantly associated with mortality. VA-ECMO is an effective strategy in treating patients with cardiogenic shock and provides a reasonable chance of survival to weaning or bridging to other therapy. Preimplantation hypoalbuminemia, preimplantation serum creatinine > 100 mmol/l, and the development of stroke and limb ischemia while on VA-ECMO are strongly associated with mortality.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 066583873

Download citation: RISBibTeXText

PMID: 30864968

Related references

Prognostic value of oxygen challenge test for patients with cardiogenic shock receiving extracorporeal membrane oxygenation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 29(12): 1102-1106, 2017

Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation. Journal of Critical Care 30(5): 949-956, 2015

Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock. Journal of Thoracic and Cardiovascular Surgery 145(3): E32-E33, 2013

Extracorporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): the need for a better definition of refractory cardiogenic shock. European Journal of Heart Failure 20(2): 197-198, 2018

Extracorporeal membrane oxygenation for refractory cardiogenic shock: patient survival and health-related quality of life. European Journal of Cardio-Thoracic Surgery 55(4): 780-787, 2019

Predictive Value of Procalcitonin for Infection and Survival in Adult Cardiogenic Shock Patients Treated with Extracorporeal Membrane Oxygenation. Chonnam Medical Journal 54(1): 48-54, 2018

The effect and factors associated with outcome of extracorporeal membrane oxygenation in refractory cardiogenic shock patients. Zhonghua Xin Xue Guan Bing Za Zhi 44(9): 777-781, 2016

Concomitant implantation of Impella ® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. European Journal of Heart Failure 19(3): 404-412, 2017

Percutaneous Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock Is Associated with Improved Short- and Long-Term Survival. Asaio Journal 62(4): 397-402, 2017

Associations with 30-day survival following extracorporeal membrane oxygenation in patients with acute ST segment elevation myocardial infarction and profound cardiogenic shock. Heart and Lung 45(6): 532-537, 2016

Veno-arterial extracorporeal membrane oxygenation for acute myocardial infarction-associated cardiogenic shock: can we predict survival before decision of implantation?. Journal of Thoracic Disease 8(9): 2331-2333, 2016

Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors. Artificial Organs 38(7): E129-E141, 2014

Concurrent Implantation of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation Improved Survival of Patients With Postcardiotomy Cardiogenic Shock. Artificial Organs 43(2): 142-149, 2019

Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score. European Heart Journal. Acute Cardiovascular Care 8(4): 329-337, 2019

Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients. Journal of Vascular Surgery 67(2): 542-548, 2018